Search the Newsreel

Calisa Acquisition Corp (NASDAQ: ALIS) agrees to $8M share sale for Goodvision deal

Earnings Flash (PSNL) Personalis, Inc. Reports Q2 Revenue $22.4M, vs. FactSet Est of $16.7M

Personalis, Inc. (PSNL) announced its Q2 revenue of $22.4 million, significantly exceeding FactSet's estimated $16.7 million. The company, which specializes in advanced cancer genomic tests and analytics, focuses on supporting personalized cancer vaccines and immunotherapies. This earnings beat follows recent news including Tempus AI's …

Personalis (NASDAQ: PSNL) Q2 revenue jumps 30% as clinical tests surge

Personalis, Inc. reported a 30% increase in Q2 2026 revenue to $22.4 million, driven by a 199% surge in clinical test volume and strong pharma testing services. Despite the revenue growth, the company posted a net loss of $31.7 million. Following a merger agreement …

PSNL Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Personalis to Tempus AI

The Monsey law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Personalis, Inc. (Nasdaq: PSNL) to Tempus AI, Inc. for $16.25 per share. The investigation comes after Tempus shares fell post-announcement, leading to a decrease in Personalis's …

Personalis: Q2 Earnings Snapshot

Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zentalis Pharmaceuticals announced that its Compensation Committee granted non-qualified stock options for 84,000 shares to two new employees. These grants were made under the 2022 Employment Inducement Incentive Award Plan, per Nasdaq Listing Rule 5635(c)(4), with an exercise price of $4.65 per share. The …

Palisade Bio (PALI) Expected to Post Earnings on Monday

Palisade Bio (PALI) is anticipated to release its Q2 2026 earnings before market open on Monday, August 10th, with analysts forecasting a loss of $0.05 per share. The company's stock opened at $1.90, near its 50-day and 200-day moving averages, and has seen insider …

Palisade Bio (PALI) Q1 2026 Earnings: Wider-Than-Expected Loss Sends Shares Down 3.32% - Tax Rate Impact

Enterprise value to EBIT forward of HC Surgical Specialists Ltd – SGX:1B1

How Investors May Respond To Tempus AI (TEM) Q2 Profit Return, Outlook Hike, Personalis Deal

Tempus AI (TEM) reported a profitable Q2 2026, swinging from a net loss to a net income of US$5.64 million, with revenue of US$382.49 million, and subsequently raised its full-year 2026 revenue outlook. The company also announced the acquisition of Personalis, enhancing its oncology …

Materialise NV (MTLS) Q1 2026 Earnings: EPS of $0.03 Beats Estimates by 194% as Shares Slip - Estimate Uncertainty

Chemfab Alkalis net profit surges 124% in Q1FY27 on tax credit

Calisa Acquisition Corp (NASDAQ: ALIS) furnishes Goodvision AI merger presentation

Calisa Acquisition Corp (ALIS) has furnished an investor presentation as Exhibit 99.1 to its 8-K filing, detailing the previously disclosed Business Combination Agreement with Goodvision AI Inc. The merger will result in Goodvision becoming a wholly owned subsidiary of Calisa. The filing emphasizes forward-looking …

Calisa Acquisition to Combine with Goodvision via Merger; investor presentation filed

Calisa Acquisition has announced a definitive merger agreement to combine with Goodvision. This will result in Goodvision becoming a wholly-owned subsidiary of Calisa. An investor presentation has been filed to discuss the transaction, and a Registration Statement including a Proxy Statement/Prospectus will be filed …

Medalist Diversified REIT Closes Kansas Automotive Property Acquisition

Medalist Diversified REIT (MDRR) has finalized the acquisition of a 1.64-acre property with a 16,100-square-foot automotive service building in Overland Park, Kansas, for $5.8 million, funded by cash on hand. The acquisition was structured through a Delaware statutory trust, allowing the REIT to offer …

Personalis Inc expected to post a loss of 26 cents a share - Earnings Preview

Personalis Inc is projected to report a loss of 26 cents per share, according to this earnings preview. The article, sourced from Reuters, provides an outlook on the company's upcoming financial performance.

Zentalis Pharmaceuticals Inc expected to post a loss of 49 cents a share - Earnings Preview

Zentalis Pharmaceuticals Inc (ZNTL) is anticipated to report a loss of 49 cents per share in its upcoming earnings announcement. This information is based on an earnings preview from Refinitiv, providing investors with an expectation for the company's financial performance.

Nexalis Therapeutics Ends June Quarter With $790,000 Cash as LFO Cancels $52.3M Funding Facility

Nexalis Therapeutics Reports $790K Cash at June Quarter End as Linlithgow Family Office Withdraws $52.3M Debt Facility

Materialise NV (MTLS) Institutional Confidence

Materialise NV (MTLS) has an institutional shareholding score of 3.00, placing it in the upper half of the Software & IT Services industry. The institutional shareholding proportion is 14.00%, showing a slight quarter-over-quarter decrease. Bill Nygren is the largest institutional shareholder, holding 0.75% of …

American Exceptionalism Acquisition Corp. (NYSE:AEXA) Short Interest Up 85.6% in July

Short interest in American Exceptionalism Acquisition Corp. (NYSE:AEXA) surged by 85.6% in July, reaching 264,381 shares, which represents 0.5% of its outstanding shares and covers 2.2 days of average trading volume. Despite this increase, the company maintains a consensus "Sell" rating from analysts, although …

Tempus AI faces earnings test after $1.5B Personalis deal By Investing.com

Tempus AI is set to report its second-quarter results, facing investor scrutiny following its $1.5 billion acquisition of Personalis Inc. This deal aims to expand Tempus's cancer-monitoring capabilities, but analysts are divided on its strategic rationale and potential impact on Tempus's path to profitability. …

Medalist Diversified, Inc. Revenue Breakdown – NASDAQ:MDRR

BlackRock (NYSE: BLK) discloses 5.2% ownership in Zentalis Pharmaceuticals (ZNTL)

BlackRock, Inc. has disclosed a 5.2% passive ownership stake in Zentalis Pharmaceuticals Inc. (ZNTL) through a Schedule 13G SEC filing. This includes 3,710,914 shares of common stock, with BlackRock holding sole voting power over 3,673,953 shares and sole dispositive power over all 3,710,914 shares. …

Chemfab Alkalis consolidated net profit rises 124.71% in the June 2026 quarter

Talisker Resources Ltd. Revenue Breakdown – TSX:TSK

Halper Sadeh LLC is Investigating Whether FNWD and PSNL are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We …

Materialise NV Sponsored ADR Revenue Breakdown – SWB:06MA

Materialise NV Sponsored ADR (SWB:06MA) generated €267.63 million in revenue last year, with its Materialise Medical segment being the top performer at €128.99 million. The United States was the largest regional contributor, accounting for €106.55 million of the total revenue. This information details the …

Borealis Foods (Nasdaq: BRLS) amends 2025 annual report after going concern note

Borealis Foods Inc. (Nasdaq: BRLS) has filed an amendment to its 2025 annual report, primarily to update auditor reports in response to a SEC comment letter. The amendment confirms that both 2025 and 2024 auditor reports highlight substantial doubt about the company's ability to …

BlackRock (PALI holder) discloses 6.0% ownership of Palisade Bio common stock

BlackRock, Inc. has reported a 6.0% beneficial ownership in Palisade Bio, Inc. common stock as of June 30, 2026, through a Schedule 13G filing. This amounts to 10,436,760 shares, representing holdings where BlackRock maintains sole voting power over 10,326,107 shares and sole dispositive power …

BlackRock (PSNL holder) discloses 5.9% beneficial stake in Personalis common stock

BlackRock, Inc. has reported a 5.9% beneficial ownership stake in Personalis, Inc. (PSNL) common stock as of June 30, 2026. This ownership, totaling 6,169,729 shares, grants BlackRock sole voting power over 6,051,493 shares and sole dispositive power over all 6,169,729 shares, as detailed in …

Inovalis REIT Stock Slides as Investors Assess Asset Sales, European Property Risks and Its Strategic Reset

Calisa Acquisition Corp Revenue Breakdown – BOATS:ALISR

This article is a financial listing for Calisa Acquisition Corp (ALISR) on TradingView, providing an overview of its financials. It indicates that the market is closed for this stock and offers information categories like statements, statistics, dividends, earnings, and segments. The content primarily focuses …

Materialise NV (MTLS) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Materialise NV (MTLS), focusing on its current price momentum, support and resistance levels, and performance across various technical indicators and moving averages. Materialise NV's price momentum score is 3.52, and the stock is trading between a resistance …

American Exceptionalism Acquisition Corp. A Revenue Breakdown – NYSE:AEXA